Clinical Trial Update: Metronomic Temozolamide in Patients With Recurrent Glioblastoma [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial update on metronomic temozolomide for patients with recurrent glioblastoma, spanning Phase 2 and Phase 3. The trial status is currently unknown…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• Temozolomide (Temozolomide)

Snippet

Sponsor: Grupo Español de Investigación en Neurooncología | Conditions: Glioblastoma | Phase 2, Phase 3 | Status: UNKNOWN